DUPIXENT ratings & reviews

Dupilumab
Company: Sanofi US
Brand: DUPIXENT
Drug class: Antineoplastic and Immunomodulating Agents
+9 more
Antineoplastic and Immunomodulating Agents, Dermatologicals, Respiratory System, Nonsteroidals For Inflammatory Skin Disorders, Agents for Reactive and Obstructive Airway Diseases, Agents that Suppress the Immune System, Interleukin-4 (IL-4) Inhibitors, Immunotherapies for Reactive and Obstructive Airway Diseases, Systemic Dermatitis Agents, Dermatitis Monoclonal Antibodies

Sermo AI Overview

  • Physicians generally regard Dupixent as well-tolerated, with many patients adhering to the treatment regimen and reporting minimal side effects, contributing to its positive reputation among healthcare providers.
  • Despite its favorable safety profile and efficacy, Dupixent faces significant barriers to accessibility, as high costs and insurance approval processes can hinder patient access to the treatment.
  • There are mixed opinions regarding Dupixent's overall effectiveness in specific cases, especially among COPD patients and some other specialties where its use is not as common, indicating variability in treatment outcomes.
  • Dupixent is recognized for its high efficacy across multiple indications, including chronic rhinosinusitis, asthma, eczema, and nasal polyps, with a strong consensus among physicians regarding its effectiveness and safety.
Based on insights from Sermo’s triple verified physicians

Description

DUPIXENT contains the active ingredient dupilumab, an interleukin-4 receptor alpha antagonist that is a human monoclonal antibody of the IgG4 subclass. It is formulated as a sterile, preservative-free solution for subcutaneous injection, available as a 300 mg pre-filled single-dose syringe or pen, and a 200 mg pre-filled syringe or pen. Key inactive ingredients include L-arginine hydrochloride, L-histidine, and polysorbate 80.

Source: This information is sourced from FDA and powered by AI

Dosage & Administration

How should I use this medication?

This medication is injected under the skin. You will be taught how to prepare and give it. Take it as directed on the prescription label. Keep taking it unless your care team tells you to stop. If you use a pen, be sure to take off the outer needle cover before using the dose. It is important that you put your used needles and syringes in a special sharps container. Do not put them in a trash can. If you do not have a sharps container, call your pharmacist or care team to get one. This medication comes with INSTRUCTIONS FOR USE. Ask your pharmacist for directions on how to use this medication. Read the information carefully. Talk to your care team if you have questions. Talk to your care team about the use of this medication in children. While this medication may be prescribed for children as young as 6 months for selected conditions, precautions do apply.

Overdosage: If you think you have taken too much of this medicine contact a poison control center or emergency room at once. NOTE: This medicine is only for you. Do not share this medicine with others.

What if I miss a dose?

It is important not to miss any doses. Talk to your care team about what to do if you miss a dose.

Where should I keep my medication?

Keep out of the reach of children and pets. Store in the refrigerator or at room temperature up to 25 degrees C (77 degrees F). Do not freeze. Keep this medication in the original packaging until you are ready to take it. Protect from light. Refrigeration (preferred): Get rid of any unused medication after the expiration date. Room temperature: This medication may be stored at room temperature for up to 14 days. Get rid of any unused medication after 14 days or after it expires, whichever is first. To get rid of medications that are no longer needed or have expired: -Take the medication to a medication take-back program. Check with your pharmacy or law enforcement to find a location. -If you cannot return the medication, ask your pharmacist or care team how to get rid of this medication safely.

NOTE: This sheet is a summary. It may not cover all possible information. If you have questions about this medicine, talk to your doctor, pharmacist, or health care provider.

Side Effects

What side effects may I notice from receiving this medication?

Side effects that you should report to your care team as soon as possible: -Allergic reactions—skin rash, itching, hives, swelling of the face, lips, tongue, or throat -Eye pain, redness, irritation, or discharge with blurry or decreased vision -Unusual weakness or fatigue, fever, headache, skin rash, muscle or joint pain, loss of appetite, pain, tingling, or numbness in the hands or feet Side effects that usually do not require medical attention (report these to your care team if they continue or are bothersome): -Cold sores -Dry eyes -Joint pain -Pain, redness, or irritation at injection site -Sore throat -Trouble sleeping

This list may not describe all possible side effects. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Warnings & Precautions

What should I tell my care team before I take this medication?

They need to know if you have any of these conditions: -Asthma -Eye disease -Parasite (worm) infection -An unusual or allergic reaction to dupilumab, other medications, foods, dyes, or preservatives -Pregnant or trying to get pregnant -Breastfeeding

What may interact with this medication?

-Live virus vaccines

This list may not describe all possible interactions. Give your health care provider a list of all the medicines, herbs, non-prescription drugs, or dietary supplements you use. Also tell them if you smoke, drink alcohol, or use illegal drugs. Some items may interact with your medicine.

What should I watch for while using this medication?

Visit your care team for regular checks on your progress. Tell your care team if your symptoms do not start to get better or if they get worse. This medication can decrease the response to a vaccine. If you need to get vaccinated, tell your care team if you have received this medication. Talk to your care team to see if a different vaccination schedule is needed. If you take this medication for asthma, you and your care team should develop an Asthma Action Plan that is just for you. Be sure to know what to do if you are in the yellow (asthma is getting worse) or red (medical alert) zones. This medication is not used to treat sudden breathing problems.

Source: This information is sourced from Elsevier Inc.

Disclaimer

The reviews, ratings, comments, and opinions expressed on this platform are solely those of the individual medical professionals who posted them and do not reflect the views or positions of Sermo, Inc. Sermo does not endorse, verify, or validate the content of individual reviews. The information provided is user-generated and reflects personal clinical experiences, which may not be complete, accurate, or applicable to your specific health needs. It is not intended as medical advice.

Prescription medications affect individuals differently, and what works for one person may not work for another. Always consult your doctor, pharmacist, or other qualified healthcare provider to ensure the information displayed applies to your personal circumstances. Only a licensed healthcare provider can advise you on what is safe and effective for you.

Keep all medications out of the reach of children, never share your medicine with others, and use each medication only as prescribed. Your reliance on any information provided on this platform is at your own risk.

Terms of use

  1. Sermo Drug Ratings, and all information provided on this website, may not be used in combination with any artificial intelligence tool (including to train an algorithm, test, process, analyze, generate output and/or develop any form of artificial intelligence tool). 

  2. Visitors to the online patient-facing website at Sermo.com (“Sermo Drug Ratings”) are Authorized Users of the website, which contains data owned by a third-party provider, Elsevier, Inc.  Accordingly, by visiting Sermo Drug Ratings, Authorized User acknowledges that the website includes Elsevier owned data that Sermo licenses pursuant to a separate usage and Data agreement (the “Agreements”).  Authorized User further acknowledges that Sermo is a third-party beneficiary of the Agreements and Authorized User’s use of the website hereby binds them to the terms of the Agreements; provided, however, that Elsevier shall have no obligations or liability to an Authorized User whatsoever pursuant to the terms of the Agreements.

Welcome to Sermo's Drug Ratings

Previously only for members, Sermo Drug Ratings are now openly available to all healthcare providers, patients, and industry professionals to support better healthcare decisions.

Clinical expertise
Insights based on real prescribing experience from triple-verified practicing physicians only
Detailed insights
Ratings on key attributes including efficacy, safety, tolerability, accessibility, and adherence
Unbiased reviews
Independent, physician-only reviews, free from pharmaceutical industry influence